Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF
Open Access
- 1 April 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 141 (7) , 1141-1150
- https://doi.org/10.1038/sj.bjp.0705716
Abstract
The prostanoid receptor(s) on human airways smooth muscle (HASM) cells that mediates the inhibitory effect of PGE2 on interleukin (IL)‐1β‐induced granulocyte/macrophage colony‐stimulating factor (GM‐CSF) release has been classified. IL‐1β evoked the release of GM‐CSF from HASM cells, which was suppressed by PGE2, 16,16‐dimethyl PGE2 (nonselective), misoprostol (EP2/EP3‐selective), ONO‐AE1‐259 and butaprost (both EP2‐selective) with pIC50 values of 8.61, 7.13, 5.64, 8.79 and 5.43, respectively. EP‐receptor agonists that have selectivity for the EP1‐ (17‐phenyl‐ω‐trinor PGE2) and EP3‐receptor (sulprostone) subtypes as well as cicaprost (IP‐selective), PGD2, PGF2α and U‐46619 (TP‐selective) were poorly active or inactive at concentrations up to 10 μM. AH 6809, a drug that can be used to selectively block EP2‐receptors in HASM cells, antagonised the inhibitory effect of PGE2, 16,16‐dimethyl PGE2 and ONO‐AE1‐259 with apparent pA2 values of 5.85, 6.09 and 6.1 respectively. In contrast, the EP4‐receptor antagonists, AH 23848B and L‐161,982, failed to displace to the right the concentration–response curves that described the inhibition of GM‐CSF release evoked by PGE2 and ONO‐AE1‐259. Inhibition of GM‐CSF release by PGE2 and 8‐Br‐cAMP was abolished in cells infected with an adenovirus vector encoding an inhibitor protein of cAMP‐dependent protein kinase (PKA) but not by H‐89, a purported small molecule inhibitor of PKA. We conclude that prostanoid receptors of the EP2‐subtype mediate the inhibitory effect of PGE2 on GM‐CSF release from HASM cells by recruiting a PKA‐dependent pathway. In addition, the data illustrate that caution should be exercised when using H‐89 in studies designed to assess the role of PKA in biological processes. British Journal of Pharmacology (2004) 141, 1141–1150. doi:10.1038/sj.bjp.0705716Keywords
This publication has 59 references indexed in Scilit:
- Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram, Salbutamol, and Prostaglandin E2: A Comparison with H-89The Journal of Pharmacology and Experimental Therapeutics, 2004
- Prostanoid receptor subtypesProstaglandins & Other Lipid Mediators, 2002
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Release of GM‐CSF and G‐CSF by human arterial and venous smooth muscle cells: differential regulation by COX‐2British Journal of Pharmacology, 2000
- Characterization of PKIγ, a Novel Isoform of the Protein Kinase Inhibitor of cAMP-dependent Protein KinasePublished by Elsevier ,1997
- Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell typeBritish Journal of Pharmacology, 1997
- Crystal Structures of Catalytic Subunit of cAMP-dependent Protein Kinase in Complex with Isoquinolinesulfonyl Protein Kinase Inhibitors H7, H8, and H89Journal of Biological Chemistry, 1996
- Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acidDigestive Diseases and Sciences, 1991
- Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival.Journal of Clinical Investigation, 1986
- The granulocyte—Macrophage colony stimulating factorsCell, 1985